Industry Analysis & Industry Trends
The Pharmaceutical Product Manufacturing industry is an important component of the pharmaceutical sector. The major global pharmaceutical groups dominate the local industry, although only a small number are engaged in secondary or actives manufacturing (i.e. active pharmaceutical ingredients). An increasing number are involved in the later stages of the manufacturing process, such as dispensing, packaging and the fill-and-finish stage. A large number of players also restrict their activities in Australia to distribution.
Industry revenue is expected to grow by a meagre 0.8% over 2013-14, as various internal and external factors take their toll. IBISWorld forecasts that the industry will generate revenue of $9.9 billion in 2013-14, up from $9.0 billion in 2008-09... purchase to read more
Industry Report - Starting a New Business Chapter
Substantial barriers to entry to the industry do exist, not least of which is the fact that the industry is becoming increasingly globalised, with major players operating on a large global scale. In Australia, eight of the top 10 companies are subsidiaries of established multinational operators with significant market strengths on both a global and local basis.
The high and rising costs of R&D, combined with declining R&D productivity pose another substantial obstacle. In Australia, the pharmaceutical industry is the second most innovative manufacturing industry. High levels of capital expenditure are also required at the onset to establish a manufacturing plant geared to producing high-cost, high-technology drugs.
Government policies can be significant barriers to entry... purchase to read more